ES2169917T3 - Sintesis de intermediarios utiles para preparar compuestos triciclicos bromo-sustituidos. - Google Patents

Sintesis de intermediarios utiles para preparar compuestos triciclicos bromo-sustituidos.

Info

Publication number
ES2169917T3
ES2169917T3 ES98928873T ES98928873T ES2169917T3 ES 2169917 T3 ES2169917 T3 ES 2169917T3 ES 98928873 T ES98928873 T ES 98928873T ES 98928873 T ES98928873 T ES 98928873T ES 2169917 T3 ES2169917 T3 ES 2169917T3
Authority
ES
Spain
Prior art keywords
formula
compound
alkyl
group
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98928873T
Other languages
English (en)
Spanish (es)
Inventor
Xing Chen
Marc Poirier
Yee-Shing Wong
Guang-Zhong Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ES2169917T3 publication Critical patent/ES2169917T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES98928873T 1997-06-16 1998-06-15 Sintesis de intermediarios utiles para preparar compuestos triciclicos bromo-sustituidos. Expired - Lifetime ES2169917T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/882,753 US5760232A (en) 1997-06-16 1997-06-16 Synthesis of intermediates useful in preparing bromo-substituted tricyclic compounds

Publications (1)

Publication Number Publication Date
ES2169917T3 true ES2169917T3 (es) 2002-07-16

Family

ID=25381267

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98928873T Expired - Lifetime ES2169917T3 (es) 1997-06-16 1998-06-15 Sintesis de intermediarios utiles para preparar compuestos triciclicos bromo-sustituidos.

Country Status (15)

Country Link
US (1) US5760232A (online.php)
EP (1) EP0991640B1 (online.php)
JP (1) JP3210023B2 (online.php)
AR (1) AR015886A1 (online.php)
AT (1) ATE214062T1 (online.php)
AU (1) AU8056898A (online.php)
CA (1) CA2293709C (online.php)
DE (1) DE69804100T2 (online.php)
DK (1) DK0991640T3 (online.php)
ES (1) ES2169917T3 (online.php)
IN (1) IN187755B (online.php)
MY (1) MY133531A (online.php)
PT (1) PT991640E (online.php)
WO (1) WO1998057958A1 (online.php)
ZA (1) ZA985207B (online.php)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998620A (en) * 1997-03-25 1999-12-07 Schering Corporation Synthesis of intermediates useful in preparing tricyclic compounds
ATE533748T1 (de) * 2002-10-03 2011-12-15 Schering Corp Enantioselektive alkylierung von trizyklischen verbindungen
WO2013102145A1 (en) 2011-12-28 2013-07-04 Global Blood Therapeutics, Inc. Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
DK3738434T3 (da) 2011-12-28 2023-12-04 Global Blood Therapeutics Inc Mellemprodukter til opnåelse af substituerede benzaldehydforbindelser og fremgangsmåder til anvendelse deraf ved øgning af vævsoxygenering
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
AU2014237330A1 (en) 2013-03-15 2015-09-17 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
BR112015021982B1 (pt) 2013-03-15 2022-12-13 Global Blood Therapeutics, Inc Compostos e seus usos para a modulação de hemoglobina
KR102280614B1 (ko) 2013-03-15 2021-07-21 글로벌 블러드 테라퓨틱스, 인크. 헤모글로빈 조정을 위한 화합물 및 이의 용도
US9604999B2 (en) 2013-03-15 2017-03-28 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10100043B2 (en) 2013-03-15 2018-10-16 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
SI3102208T2 (sl) 2014-02-07 2024-10-30 Global Blood Therapeutics, Inc. Kristalinični polimorf proste baze 2-hidroksi-6-((2-(1-izopropil-1H-pirazol-5-IL)piridin-3-IL)metoksi)- benzaldehida
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
US11020382B2 (en) 2015-12-04 2021-06-01 Global Blood Therapeutics, Inc. Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
AR108435A1 (es) 2016-05-12 2018-08-22 Global Blood Therapeutics Inc Proceso para sintetizar 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)-piridin-3-il)metoxi)benzaldehído
TWI778983B (zh) 2016-10-12 2022-10-01 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
EP3860975B1 (en) 2018-10-01 2023-10-18 Global Blood Therapeutics, Inc. Modulators of hemoglobin for the treatment of sickle cell disease
WO2020163689A1 (en) 2019-02-08 2020-08-13 University Of Pittsburgh - Of The Commonwealth System Of Higher Education 20-hete formation inhibitors
CN112341433A (zh) * 2020-11-16 2021-02-09 成都大学 一种氯雷他定的制备方法
WO2024251227A1 (zh) * 2023-06-08 2024-12-12 上海森辉医药有限公司 一种甲酰胺类化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089496A (en) * 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
SG48750A1 (en) * 1993-10-15 1998-05-18 Schering Corp Tricyclic carbonate compounds useful for inhabition of g-protein function for treatment of proliferative diseases
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
CZ292791B6 (cs) * 1995-12-22 2003-12-17 Schering Corporation Tricyklické amidy, které se používají pro inhibici G-proteinové funkce a k léčení proliferativních onemocnění

Also Published As

Publication number Publication date
CA2293709C (en) 2004-02-10
WO1998057958A1 (en) 1998-12-23
CA2293709A1 (en) 1998-12-23
PT991640E (pt) 2002-07-31
DE69804100D1 (de) 2002-04-11
IN187755B (online.php) 2002-06-15
US5760232A (en) 1998-06-02
ATE214062T1 (de) 2002-03-15
JP2000513032A (ja) 2000-10-03
AR015886A1 (es) 2001-05-30
DE69804100T2 (de) 2002-10-31
EP0991640B1 (en) 2002-03-06
AU8056898A (en) 1999-01-04
DK0991640T3 (da) 2002-05-27
EP0991640A1 (en) 2000-04-12
JP3210023B2 (ja) 2001-09-17
ZA985207B (en) 1999-04-07
MY133531A (en) 2007-11-30

Similar Documents

Publication Publication Date Title
MY133531A (en) Synthesis of intermediates useful in preparing bromo-substituted tricyclic compounds
CO5140073A1 (es) Derivados de 2,3,4,5-tetrahidro-1h-3-benzapina
DK633088A (da) Kollagenaseinhibitorer
CO5590960A2 (es) Derivados de azaindolilalquilamina como ligandos de 5- hidroxitriptamina-6
AR052915A1 (es) Derivados de pirrolidin y piperidin acetileno
GT200300003A (es) Derivados de acido acetico
AR023381A1 (es) Nuevo derivado de tiazolbenzoimidazol
CO4940446A1 (es) Compuestos 4-aminopirido[2,3-d]pirimidina 5,7-disustituidos
KR840006641A (ko) 2,6-피페리딘디온 유도체의 제조방법
AR008168A1 (es) Compuestos etilamino arilamida aril substituidos de pirrolidinilo y pirrolinilo, composicion farmaceutica que lo contiene, compuesto util para susintesis, procedimiento para su preparacion
NO20071253L (no) Fremgangsmate for syntese av C-2, C-3 substituerte N-alkylerte indoler anvendbare som CPLA2-inhibitorer.
Kanner et al. Reaction of β-amino-α, β-unsaturated esters and amides with aryl diazonium salts: Synthesis of cinnoline derivatives
RU94041212A (ru) Способ получения производных 0-[4-(4-пиперидинил)бутил]тирозина
AR013183A1 (es) Procedimiento para producir un compuesto derivado de indol, compuestos obtenidos e intermediarios
AR044943A1 (es) Procedimiento para la sintesis de perindopril y sales farmaceuticamente aceptables del mismo
TR200401488T4 (tr) CNS bozukluklarının tedavisinde faydalı indol türevleri
CO5150208A1 (es) Compuestos de dihidropiridina ciclopentanona utiles como abridores de canales de potasio
CO4940478A1 (es) Derivados de 1-(2-acilimidazol-1-ilalquil) quinuclidino
CO4810299A1 (es) Procedimiento para alquilar sulfonamidas impedidas esteri- camente
AR038931A1 (es) Proceso para la preparacion de piperazinas quirales 1,4-disustituidas
EP0812838A4 (en) PYRIDONE CARBONIC ACID DERIVATIVES SUBSTITUTED BY BICYCLIC AMINO GROUP, THEIR ESTERS AND SALTS, AND BICYCLIC AMINE AS INTERMEDIATE PRODUCT THEREOF
AR036635A1 (es) Difosfina, catalizador de carbonilacion que la contiene y procedimiento para la obtencion de un acido alquenocarboxilico o uno de sus derivados por carbonilacion de un dieno conjugado que lo emplea
GB1380794A (en) Glutaric acid imides and processes for their preparation
AR023528A1 (es) Derivados de ciclobuten-3,4-diona, su preparacion y su aplicacion en terapeutica
ES406767A1 (es) Procedimiento para la preparacion de nuevos derivados de indol.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 991640

Country of ref document: ES